In this study, we found that DHT was able to induce Porimin-dependent oncosis via ROS-mediated mitochondrial dysfunction in vivo and in vitro, which indicates that DHT is a potential drug for the treatment of NSCLC. Here, TMEM123 is linked to non-small cell lung carcinoma.